Poster Sessions
ejc supplements 8, no. 5 (2010) 5–81
with the development of peptic ulcer disease, atrophic gastritis, and gastric
adenocarcinoma. Virulent Hp isolates harbor the cag (cytotoxin-associated
genes) pathogenicity island (cagPAI), a 40 kb stretch of DNA that encodes
components of a type IV secretion system (T4SS). This T4SS forms a pilus
for the injection of virulence factors into host target cells, such as the CagA
oncoprotein. In a previous study a very strong association between current
infection with cagA-positive Hp strains and the severity of gastric precancerous
lesions has been showed.
Material and Methods: We analyzed the genetic variability in CagA and other
selected genes of the Hp PAI, using DNA extracted from frozen gastric biopsies
or from cultured strains from patients with gastric preneoplastic or cancer
lesions. Patients where from Venezuela, Mexico and Paraguay, areas with high
prevalence of Hp infection and gastric cancer. Because of the high genetic
variability of the Hp genome, the study required a thorough optimization of the
experimental conditions. Thus, sequencing reactions were carried out by both,
Sanger and next-generation pyrosequencing (454 Roche) methods.
Results: Sequence analysis showed high variability in most of the cagPAI
genes we have tested. In particular, the cagA gene showed striking ethnic and
individual variation in its C-terminal region, where repetitive phosphorylation
(EPIYA) motifs are located. We found different combinations of these
biologically important EPIYA types.
Conclusions: This first analysis confirms the presence of high variability in the
Hp PAI genes, which warrants further investigations for the risk of neoplastic
progression within CagA positive patients.
94 Withdrawn
95 Associations between functional EGFR polymorphisms and glioma
risk
B.M. Costa1 , M. Viana-Pereira1 , S. Costa1 , J. Lima2 , P. Soares2 , J. Amorim3 ,
P. Linhares4 , C. Pinheiro5 , P. Oliveira6 , R.M. Reis1 . 1 University of Minho,
Life and Health Sciences Research Institute (ICVS) School of Health
Sciences, Braga, Portugal, 2 IPATIMUP, Institute of Molecular Pathology
and Immunology, University of Porto, Porto, Portugal, 3 Hospital S. Marcos,
Department of Oncology, Braga, Portugal, 4 Hospital S. João, Department
of Neurosurgery, Porto, Portugal, 5 Hospital Santo António, Department
of Neurosurgery, Porto, Portugal, 6 University of Minho, Department of
Production and Systems Engineering, Braga, Portugal
Background: The epidermal growth factor receptor (EGFR) regulates
important cellular processes and is frequently implicated in human tumours.
Somatic alterations of this receptor tyrosine kinase influence several
mechanisms of malignant transformation and are common in gliomas. In
addition, germline EGFR functional polymorphisms may have implications in
carcinogenesis. Two single nucleotide polymorphisms (SNPs) were found in
the essential promoter region (−216G/T and −191C/A) of the EGFR gene.
The −216G/T has functional consequences, with the T allele being associated
with higher promoter activity, resulting in increased gene expression both in
vitro and in vivo. Additionally, a highly polymorphic microsatellite sequence
(CA)n repeat in intron 1 of EGFR has been shown to be functional, as
the transcriptional levels of EGFR decline with increasing numbers of (CA)n
repeats. In the present study, we aimed to elucidate the roles of these EGFR
polymorphisms in glioma susceptibility and prognosis.
Material and Methods: We conducted a case-control study with 245 glioma
patients and 412 cancer-free controls from Portugal. Genetic variants of
EGFR were determined by PCR-RFLP analysis (for −216G/T and −191C/A)
or by PCR followed by single capillary genetic analysis [for (CA)n repeat].
Univariate and unconditional multivariate logistic regression models were used
to calculate odds ratio (OR) and 95% confidence intervals (95% CI). A Coxregression model was used to evaluate patient survival.
Results: The allele frequencies of −216G/T, −191C/A, and (CA)n repeat
polymorphisms in the cancer-free control group in our study are similar to
those previously reported in American Caucasian populations. Associations
between EGFR −216G/T and −191C/A variants and glioma risk were
not statistically significant (p > 0.05). Furthermore, no associations were
found when glioma patients were stratified by histological types (e.g.,
astrocytoma and oligodendroglioma). In contrast, shorter variants of the
intron 1 (CA)n repeat conferred higher risks for gliomas, glioblastomas, and
oligodendrogliomas (P < 0.05). No associations were observed between EGFR
polymorphisms and patient outcomes.
Conclusions: Our data do not implicate EGFR −216G/T and −191C/A
polymorphisms as risk factors for gliomas, but suggest the length of EGFR
(CA)n repeat in intron 1 as a susceptibility factor for development of gliomas.
Future studies are warranted to investigate how these EGFR genetic variants
may affect therapeutic responses, particularly to EGFR-targeted therapies
currently tested in clinical trials for glioma patients.
25
96 Adiponectin functional polymorphisms and haplotype are
associated with prostate cancer aggressiveness and to hormonal
castration resistance
V. Cunha1 , R. Ribeiro1 , A. Azevedo1 , C. Monteiro1 , F. Pina2 , A. Fraga3 ,
F. Calais da Silva4 , F. Lobo5 , R. Medeiros6 . 1 Oncology Portuguese
Institute, Molecular Oncology, Oporto, Portugal, 2 Hospital S. João, Urology
Department, Oporto, Portugal, 3 Porto hospital Centre, Urology Department,
Oporto, Portugal, 4 Central Lisbon Hospital Centre, Urology Department,
Lisbon, Portugal, 5 Portuguese Institute of Oncology, Urology Department,
Oporto, Portugal, 6 Portuguese Institute of Oncology, Molecular Oncology,
Oporto, Portugal
Background: Adipokines have been proposed as mediators in the association
between obesity and prostate cancer (PCa). Recent findings described
that higher prediagnostic adiponectin levels predispose men to a lower
risk of developing high-grade prostate cancer. Functional polymorphisms
and haplotypes in ADIPOQ gene (ADIPOQ+45T>G, ADIPOQ+276G>T and
haplotype +45/+276) seem to influence adipoQ circulating levels.
Material and Methods: We conducted a prospective study in biopsyproven PCa patients (n = 944). Patients were appropriately followed in the
clinical setting for a median time of 39.4 months (3.2 to 231.5 months).
Polymorphisms were genotyped through PCR-RFLP and Real Time-PCR.
Haplotypes were derived from ADIPOQ+45 and ADIPOQ+276 genotypes and
analysed according to the adiponectin production genetic profile.
Results: Results presented evidence that TT carriers of ADIPOQ+276 had
increased risk for higher Gleason score (OR = 1.99; 1.2−3.3 p = 0.004). In the
polymorphism at locus +45 an association was observed between higher levels
of testosterone at diagnosis and carrying GG genotype (p = 0.012). Univariate
Kaplan-Meier function plots analysis showed a shorter time to hormonal
castration resistance in TT carriers of ADIPOQ+276G>T polymorphism, when
compared with G carriers (54.4 and 93.2 months, respectively; p = 0.006).
Combined haplotypic analysis showed an increased risk for Gleason 8
with high/intermediate ADIPOQ expression genetic profile (OR = 1.92, 95%CI:
1.3−2.8; p = 3.7×10−4 ). This genetic profile was also associated with a higher
body mass index (BMI) (p = 0.022). Kaplan–Meier function plots analysis
showed shorter time to hormonal castration resistance in high/intermediate,
when compared with Low adiponectin producers (54.4 and 96.7 months,
respectively; p = 3.6×10−4 ). After multivariate Cox Regression analysis, using
as covariants stage of disease, Gleason score and PSA at diagnosis, the
high/intermediate adiponectin producers evidenced an increased risk for
developing resistance to hormonal castration (HR = 1.8, 95% CI: 1.1−2.9;
p = 0.027).
Conclusions: Functional ADIPOQ genotypes and haplotypes that correlate
with circulating adiponectin levels might be associated with genetic
susceptibility for PCa aggressiveness and shorter progression-free interval
during hormonal castration treatment.
97 Non-synonym leptin receptor genetic variants, prostate cancer
susceptibility and aggressiveness
C. Monteiro1 , R. Ribeiro1 , A. Azevedo1 , V. Cunha1 , A. Fraga2 , F. Pina3 ,
F. Calais da Silva4 , F. Lobo5 , R. Medeiros1 . 1 Portuguese Institute of
Oncology, Molecular Oncology, Porto, Portugal, 2 Porto Hospital Centre,
Urology Department, Porto, Portugal, 3 Hospital S. João, Urology Department,
Porto, Portugal, 4 Central Lisbon Hospital Centre, Urology Department,
Lisbon, Portugal, 5 Portuguese Institute of Oncology, Urology Department,
Porto, Portugal
Background: Leptin is a hormone synthesized preferentially in adipose tissue.
Circulating levels are well correlated with obesity status while its receptor
(LEPR) was found to be overexpressed in prostate tumoural cells besides
the central nervous system. We hypothesized that 3 non-synonymous LEPR
polymorphisms (Gln223Arg, Lys656Asn and Lys109Arg) may be associated
with prostate cancer (PCa) risk and aggressiveness.
Methods: This case-control study was conducted in histologically confirmed
PCa (n = 1382) and benign disease patients (n = 471). We used Real-Time
PCR and PCR-RFLP in order to investigate genotype distributions of the LEPR
polymorphisms in these populations.
Results: Age- and BMI-adjusted binary logistic regression showed decreased
PCa risk for LEPR Gln223Arg Arg carriers (aOR = 0.56; 95% CI = 0.38–
0.83; P = 0.003). Cumulatively, we observed an association between LEPR
Lys656Asn Asn carriers with higher Gleason score (P = 0.008). In PCa
patients, multivariate Cox regression analysis evidenced that LEPR Lys109Arg
Lys carriers had lower time-to-bone metastasis (HR = 0.37; 95% CI = 0.14–
0.95; P = 0.039), after adjustment for Gleason score, stage of disease and
PSA level.
Conclusions: Results from this large study using biopsy-proven absence of
PCa in the control group, suggest that the non-synonymous polymorphism
LEPR Gln223Arg is associated with PCa development and may be a potential
molecular marker of susceptibility. Conversely, the polymorphism LEPR
Lys109Arg might be linked with bone metastasis mechanisms, influencing the
26
ejc supplements 8, no. 5 (2010) 5–81
time-to-onset of bone spread. LEPR Lys656Arg may be involved in tumour
differentiation, thus influencing Gleason grade.
98 Association between primary brain tumours and specific IgE levels,
measured in participants of the EPIC cohort study
B. Schlehofer1 , B. Siegmund1 , J. Linseisen2 , J. Wahrendorf1 , J. Schüz3 ,
EPIC Brain Cancer Group4 . 1 German Cancer Research Center, CO30,
Heidelberg, Germany, 2 Helmholtz Center, Institute for Epidemiology,
München, Germany, 3 Institute of Cancer Epidemiology, Biostatistics and
Epidemiology, Copenhagen, Denmark, 4 IARC, Epic, Lyon, France
Background: Epidemiological studies investigating the association between
allergic or atopic diseases, including asthma, hay fever or eczema (atopic
eczema), and primary brain tumours (glioma, meningioma, schwannoma)
showed nearly all an inverse association between glioma, with the less
consistent results for meningioma. Only few cohort studies exist presenting
with conflicting results. At the moment, no conclusive biological mechanism is
known.
Our study investigates in frame of a large international cohort study based on
specific IgE-levels the association between atopic condition and primary brain
tumours.
Material and Methods:A nested case-control study has been conducted
in frame of the EPIC (European Prospective Investigation into Cancer and
Nutrition) brain tumour cohort. The serum samples were collected from the
participants of this large international, multi-centric prospective cohort study,
in general several years before the diagnosis of the brain tumour. 216 glioma,
137 meningioma and 39 schwannoma cases were available for testing. In total
595 controls sera were randomly selected from the cohort and matched to
the cases according study centre, gender, data of birth, age, date and time of
blood selection, and length of follow-up. ORs and their 95% CI were calculated
using conditional logistic regression analyses. Adjustment has been done for
educational level, smoking status, alcohol consumption, physical activity and
hormone replacement therapy (for women only).
Results and Conclusion: In general the results of this cohort study confirm
those of the case control studies. Using sera for testing specific IgE levels
instead of questionnaire data from case-control participants avoid information
and recall bias due to memory gaps and to missing symptoms although an
atopic condition exists. Limitations and strength of the study design should be
discussed, especially the issue of possible biological hypotheses.
Sunday 27 June 2010
100 Cancer incidence in the Republic of Belarus: from 1970 to 2030
I. Veyalkin1 , Y.U. Averkin1 , S. Krasny1 . 1 N.N. Alexandrov Research Institute
of Oncology & Medical Radiology, Cancer Epidemiology, Minsk, Belarus
Background: Cancer incidence rates grow dramatically in the world. 25.0
million new cancer cases are expected to be registered in 2030. This cancer
burden is supposed in Belarus too. Thus we will need to prepare the medical
service for new conditions and design new approaches in cancer prevention.
Methods: The data of obligatory cancer registration were studied for the past
39 years. Age Standardized Incidence Rates (ASRWorld per 100,000) in males
and females (urban and rural) were calculated. Absolute numbers of cancer
incidence were analyzed and predicted up to 2030 in compliance with agespecific rates trends and demographic situation prognosis.
Results: In 1970 13,983 new cancer case were established in Belarus. This
number has grown to 40,744 to 2008. This increase was caused partially by
population ageing and by growth of age-specific rates due to cancerogenic
factors affection. Constant growth of ASR was noted for colon cancer and
melanoma of skin in both males and females and for breast, corpus uteri
and renal female cancers. Incidence rates for skin cancers in the both sexes,
prostatic and renal cancer in males slowly increasing from the 1970s started
growing rapidly in the middle of the 1990s. But considerable decrease was
shown in ASR of males and females stomach cancer as in lip cancer in
males. ASR for female and male recto-sigmoidal cancer and male cancers
of oesophagus, larynx, lung and bladder had been increasing till the middle
of the 1990s to be fixed at a certain level then. Thyroid cancer incidence
jumped immediately after Chernobyl disaster from 0.45 in 1970 and 0.77 in
1986 to 3.1 in 2003 (males) and from 0.81 in 1970 and 1.71 in 1986 to 14.7
in 2003 (females). Since 2003 morbidity has been flatten out in males and
started decreasing in females. Thyroid cancer incidence rates have returned
to before-Chernobyl level in children age-groups but they continue increased
in elder cohorts. It is expected that the population of Belarus will decrease by
one million persons (10% from the 2008 level) but the proportion of 55 years
old people will increase in 25% from 2008 to 2030. Most important cancers
incidence rates grow rapidly exactly in people who are 55 years and elder.
Both ageing of population and cancerogenic factors impact allow us to predict
the 60,000 new registered cancer cases in 2030.
Conclusions: To ease the result of our expectancies we need to start realizing
cancer screening programs, especially reinforcing prevention activity and
expanding heath care and medical education systems in part of oncology.
101 Tumours of salivary glands from diagnosis to management
99 Cycloxygenase-2 (COX2) expression in transitional cell carcinoma
of the bladder does not confer independent prognostic properties
M. Czachorowski1 , F.X. Real2 , J. Lloreta3 , D.T. Silverman4 , M. Morente5 ,
S. Kishore3 , M. Kogevinas3 , N. Malats1 . 1 CNIO, Genetic and Molecular
Epidemiology Group, Madrid, Spain, 2 CNIO, Eptithelial Carcinogenesis
Group, Madrid, Spain, 3 IMIM, Epidemiology, Barcelona, Spain, 4 NCI,
Epidemiology, Bethesda, USA, 5 CNIO, Biobank Group, Madrid, Spain
Background: Cyclooxygenase-2 (COX2) is responsible for maintaining an
acute inflammatory state in the body and its aberrant overexpression can
trigger chronic inflammation and cancer. The link between inflammation and
bladder cancer has provided the impetus for many studies to evaluate the
prognostic significance of COX2 in this tissue with no clear consensus
on independent prognostic potential having been made. Using, one of the
largest cohorts of Transitional Cell Carcinomas (TCC), we attempted to further
elucidate the independent prognostic potential of COX2 expression in bladder
cancer.
Methods: Tissue microarrays containing 557 non-muscle invasive (NMIT)
and 216 muscle invasive (MIT) bladder tumours collected as part of the
Spanish Bladder Cancer study, were analyzed by immunohistochemistry using
computerized quantitative image analysis technology. COX2 expression was
assessed as a product of staining intensity and area, providing a continuous
protein expression gradient. Univariate and multivariate Cox-proportional
hazards statistics were then applied to determine whether COX2 expression
was an independent prognostic marker for recurrence and progression in
NMITs, and progression and disease-specific survival in MITs.
Results: COX2 protein expression was associated with tumour stage
(p < 0.0001) and grade (p < 0.0001) in NMITs. Maintaining COX2 expression
as a continuous variable in univariate analysis yielded an association with
increased recurrence in NMITs (hazard ratio [HR] 1.019 [95% CI 1.000–
1.038], p = 0.048), while a dichotomous expression score was associated with
a decrease in progression of NMITs (HR 0.448 [0.252–0.795], p = 0.01). These
associations did not maintain significance in the multivariate analysis.
Conclusions: To our knowledge, this study makes use of the largest cohort of
TCCs to be analyzed for COX2 expression, and recapitulates the association
of COX2 expression with other established cancer markers. However, there is
lack of evidence to support that COX2 expression can be used as an accurate,
independent prognostic marker in bladder cancer.
L. Al-Azzawi1 , H. Al-Sammarraie1 . 1 University of Baghdad, Pathology,
Baghdad, Irak
Background: The three major salivary glands plus the hundreds of small
minor salivary gland locates within the submucosa of the oral cavity and
oropharynx are capable of giving rise to a wide range of neoplasms. The vast
majority of salivary neoplasms are epithelial in origin. The ratio of benign to
malignant salivary gland tumours is gland dependent. Epithelial salivary gland
tumours are relatively uncommon and constitute a wide spectrum of variable
morphologic and biologic entities. Among these cytological and morphological
properties of salivary gland tumours, one of the most important criteria for
measuring its biological behaviour and aggressiveness is cell proliferation. The
cell proliferation/death balance is most important in the development of salivary
gland tumours.
Material and Methods: Forty nine formalin fixed paraffin embedded
tissue blocks of epithelial salivary gland tumours were used in this
study. Haematoxylin and Eosin stain was used for reassessment of the
histopathologic diagnosis. The cell proliferation activity was examined by
proliferating cell nuclear antigen (PCNA) and Ki 67 immunohistochemistry and
proapoptotic cell death Bax and Bcl-2 mRNA genes was analysed by in situ
hybridization techniques.
Results: The parotid glands expressed a high frequency of affected site
and about 25% demonstrated malignant behaviors while the minor salivary
glands the frequency rate were account for 25% and have ability to
demonstrated malignant behavior to 50%. Immunohistochemical analysis
show high expression of PCNA and Ki 67 was noted in 8 of 12 pleomorphic
adenoma cases (66.67%), 15 of 19 adenoid cystic carcinoma cases
(78.95%), 6 of 7 mucoepidermoid carcinoma cases (85.71%), and 3 of
5 adenocarcinoma cases (60%). Significant difference was found between
labeling index of benign and malignant salivary gland tumours, while no
significant relationship was noted in labeling index between adenoid cystic
carcinoma and mucoepidermoid carcinoma neither between mucoepidermoid
carcinoma and adenocarcinoma.
In situ hybridization detection show low expression of Bax and was noted in
pleomorphic adenoma cases (25%), in adenoid cystic carcinoma cases (52.63
%), however, mucoepidermoid carcinoma showed high expression of these
markers than other salivary gland tumours, whereas adenocarcinoma show
equal number of cases expressed both PCNA protein and Bax mRNA. No
significant relationship was demonstrated between the immunostaining PCNA,